comparison effect of Ondansetron and Halopridol and Dexmedetomidine for ?? prophylaxis of postoperative nausea and vomiting in patients undergoing ?total abdominal hysterectomy ?

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N84

Enrollment

114

Registered

2018-08-29

Start date

2017-10-08

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abdominal hysterectomy ?. Prolapse of vaginal vault after hysterectomy

Interventions

Intervention 1: Intervention group: In the Haloperidol group, 2 milligrams of Haloperidol are given intravenously (equivalent to one milliliter). Intervention 2: Intervention group: In the Ondansetro

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All patients are candidates for abdominal hysterectomy ASA class I and II No history of psychiatric and psychology The absence of Parkinson's disease, motion sickness or chemotherapy history Patients under general anesthesia Patients aged 35-60 years Maximum surgical duration 150 minutes

Exclusion criteria

Exclusion criteria: Surgical duration time more than150 minutes

Design outcomes

Primary

Measure	Time frame
Vomiting score. Timepoint: 4 and12 and 24 hours after surgery. Method of measurement: Vomitting score.;Nausea. Timepoint: After surgery. Method of measurement: Clinical observation.;Sedation. Timepoint: In recovery. Method of measurement: Ramsy score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Maryam Shokrpour

Arak University of Medical Sciences

shokrpour@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026